The 2025 Eli Lilly and Company Grand Challenge Grant Application invites participants to compete for $100,000 in non-dilutive grant funding, with the opportunity to network with Lilly executives and scientists. The challenge will focus on two major tracks: Women’s Health, which includes autoimmune disease, cardiometabolic, and reproductive health, and Genetic Medicine, which covers novel delivery technologies, neuroscience, and regenerative medicine.

Researchers interested in applying must submit their application by June 27th, 2025. Applications must be non-confidential, as any containing confidential information will be discarded. To learn more about this opportunity, visit the application page here.